The Lupus Market report, compiled recently by Market Research Future, examines the industry in terms of the global expanse, highlighting the present & future growth potential of each region as well as consolidated statistics.
Lupus is a systemic autoimmune disease that induces inflammation throughout the body. The immune system attacks healthy tissues and cells of the body in patients with lupus, which can damage various parts of the body, including the skin, joints, kidneys, heart, lungs, blood vessels, and brain.
According to Market Research Future (MRFR), The global Lupus Market Statistics is projected to grow substantially over the forecast period. The global lupus market held a valuation of USD 1.48 billion in 2017 and is anticipated to expand at a CAGR of 11.2% from 2018 to 2023 (forecast period).
Market Dynamics
Factors such as the increasing prevalence of lupus, ongoing medical advances in the treatment of systemic lupus erythematosus, and increased research and development activities are anticipated to push market growth during the forecast period. As per the Lupus Foundation of America, nearly 1.5 million Americans have a form of lupus, and about 16,000 new cases are reported annually in the Americas. Despite the drivers, factors such as strict government regulation and rising prices of lupus drugs may inhibit the growth of the market during the assessment period.
Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/6636
Market Segmentation
The global market for lupus has been segmented into types, treatment, and end-user.
On the basis of type, the global lupus market has been segmented into cutaneous lupus erythematosus, systemic lupus erythematosus, neonatal lupus, cutaneous lupus erythematosus, and drug-induced lupus erythematosus. The segment for systemic lupus erythematosus is anticipated to hold the largest market share due to its growing prevalence and rising drug development in recent years.
On the basis of treatment, the global lupus market has been segmented into immunosuppressants, nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarial drugs, corticosteroids, biologics, and other.
On the basis of the end-user, the global lupus market has been segmented into hospitals & clinics, diagnostic laboratories, and others.
Regional Analysis
Region-wise, the global lupus market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas are anticipated to dominate the global market for lupus due to the growing demand for improved treatment options, increasing prevalence of lupus, government programs for lupus, and availability of reimbursement. In addition, the development of the healthcare infrastructure and the accessibility of biologics are projected to promote the growth of the market in the region.
Europe is set to retain the second-largest position in the global market for lupus. Market growth in this region is driven by the increasing number of research and development activities and the growing prevalence of lupus in the region.
The Asia Pacific region is anticipated to be the fastest-growing region due to the increasing prevalence of lupus, the continuous growth of the healthcare sector, and the rising regional expansion of prominent market players. As reported by the Australian Society of Clinical Immunology and Allergy, more than 20,000 people in Australia and New Zealand were affected by lupus in 2016.
The Middle East and Africa has the lowest market share. The majority of the market in this area is projected to be held by the Middle East region owing to a well-developed healthcare sector and increasing government initiatives in the healthcare sector.
Key Players
Some of the significant participants in the global lupus market are Bristol-Myers Squibb Company, Aurinia Pharmaceuticals, Inc., Cadila Healthcare, GlaxoSmithKline plc, Mylan N.V., F. Hoffmann-La Roche AG, Pfizer, Inc., Sanofi, Lycera Corporation, Merck KGaA, and Eli Lily and Company. Prominent players in the industry are active in the production of new products and product launches.
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.
No comments:
Post a Comment